key: cord-1047440-nwidsqiu
authors: Jain, Mukesh Kumar; Sahu, Sanjay Kumar; Behera, Jyoti Ranjan; Patnaik, Sibabratta
title: Multisystem Inflammatory Syndrome in Children Associated with COVID 19 Treated with Oral Steroid
date: 2020-09-15
journal: Indian J Pediatr
DOI: 10.1007/s12098-020-03497-4
sha: db30e949ce43e07b094f60d70cd5b52dd6006c9c
doc_id: 1047440
cord_uid: nwidsqiu

nan

diagnosis was made, child had dramatic clinical improvement. Hence oral steroid was continued. Inflammatory and biochemical parameters normalized on day 5. Child was discharged on day 7 with oral steroid for 2 wks.

As the pandemic is growing exponentially, all pediatricians should be aware of MIS-C, which will help in prompt diagnosis and management. Treatment options are IVIG, intravenous steroids and biologics like tocilizumab among which IVIG being the preferred one. Oral steroids may be considered as a treatment option in milder forms (without features of shock or cardiac involvement) but require more extensive trials before recommendation.

Multisystem inflammatory syndrome with features of atypical kawasaki disease during COVID-19 pandemic

Multisystem inflammatory syndrome in children and adolescents with COVID-19. Scientific brief: World Health Organisation

Emergency preparedness and response: Health alert network

Multisystem inflammatory syndrome in children in COVID-19 pandemic

Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

Conflict of Interest None.